Below are the financial statements of Vitrolife, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of SEK | 2024 | 2023 |
|---|---|---|
| Net sales | 3,609a | 3,512a |
| Cost of sales | -1,470a | -1,534a |
| Gross income | 2,139a | 1,977a |
| Selling expenses | -754a | -684a |
| Administrative expenses | -478a | -433a |
| Research and development costs | -117a | -127a |
| Other operating income | 11a | 5a |
| Other operating expenses | -18a | -4,328a |
| Operating income | 783a | -3,589a |
| Net financial items | — | — |
| Financial income | 25a | 19a |
| Financial expenses | -134a | -142a |
| Income after financial items | 674a | -3,712a |
| Appropriations (Group contribution received) | 0a | 0a |
| Income taxes | -160a | -139a |
| Income for the year | 514a | -3,851a |
| Attributable to parent company shareholders | 513a | -3,851a |
| Non-controlling interests | 1a | 0a |
| Depreciation, amortisation and impairment | -442a | -4,725a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Vitrolife’s data sources below and access millions more through our Disclosure Search.